Attenuation of Chondrogenic Transformation in Vascular Smooth Muscle by Dietary Quercetin in the MGP-Deficient Mouse Model

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Beazley, Kelly E ^a   Lima, Florence ^a   Borras, Teresa ^b   Nurminskaya, Maria ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CALCIUM PHOSPHATE; MATRIX GLA PROTEIN; OSTEOCALCIN; QUERCETIN; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CALCIFICATION; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHONDROGENESIS; CONTROLLED STUDY; METAPLASIA; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; BETA CATENIN; CALCIUM-BINDING PROTEINS; CHONDROGENESIS; DNA PRIMERS; EXTRACELLULAR MATRIX PROTEINS; IMMUNOHISTOCHEMISTRY; LUCIFERASES; METAPLASIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; QUERCETIN; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC; VASCULAR CALCIFICATION;

EID: 84884789599     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076210     Document Type: Article

References (81)

1. Iyemere VP, Proudfoot D, Weissberg PL, Shanahan CM, (2006) Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med 260: 192-210. doi:10.1111/j.1365-2796.2006.01692.x. PubMed: 16918817.
2. Lacolley P, Regnault V, Nicoletti A, Li Z, Michel JB, (2012) The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc Res 95: 194-204. doi:10.1093/cvr/cvs135. PubMed: 22467316.
3. Nguyen AT, Gomez D, Bell RD, Campbell JH, Clowes AW, et al. (2013) Smooth muscle cell plasticity: fact or fiction? Circ Res 112: 17-22. doi:10.1161/CIRCRESAHA.112.281048. PubMed: 23093573.
4. Ng K, Hildreth CM, Phillips JK, Avolio AP, (2011) Aortic stiffness is associated with vascular calcification and remodeling in a chronic kidney disease rat model. Am J Physiol Renal Physiol 300: F1431-F1436. doi:10.1152/ajprenal.00079.2011. PubMed: 21478483.
5. Spin JM, Maegdefessel L, Tsao PS, (2012) Vascular smooth muscle cell phenotypic plasticity: focus on chromatin remodelling. Cardiovasc Res 95: 147-155. doi:10.1093/cvr/cvs098. PubMed: 22362814.
6. Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM, (2011) Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 109: 697-711. doi:10.1161/CIRCRESAHA.110.234914. PubMed: 21885837.
7. Bostrom KI, Rajamannan NM, Towler DA, (2011) The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ Res %19;109: 564-577.
8. Nemenoff RA, Horita H, Ostriker AC, Furgeson SB, Simpson PA, etl. al (2011) SDF-1alpha induction in mature smooth muscle cells by inactivation of PTEN is a critical mediator of exacerbated injury-induced neointima formation. Arterioscler Thromb Vasc Biol 3Yanvar:(1300-1308). doi:10.1161/ATVBAHA.111.223701. PubMed: 21415388.
9. Wamhoff BR, Hoofnagle MH, Burns A, Sinha S, McDonald OG, et al. (2004) A G/C element mediates repression of the SM22alpha promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis. Circ Res 95: 981-988. doi:10.1161/01.RES.0000147961.09840.fb. PubMed: 15486317.
10. Price PA, Faus SA, Williamson MK, (1998) Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 18: 1400-1407. doi:10.1161/01.ATV.18.9.1400. PubMed: 9743228.
11. Essalihi R, Dao HH, Yamaguchi N, Moreau P, (2003) A new model of isolated systolic hypertension induced by chronic warfarin and vitamin K1 treatment. Am J Hypertens 16: 103-110. doi:10.1016/S0895-7061(02)03204-1. PubMed: 12559675.
12. Beazley KE, Banyard D, Lima F, Deasey SC, Nurminsky DI, et al. (2012) Transglutaminase Inhibitors Attenuate Vascular Calcification in a Preclinical Model. Arterioscler Thromb Vasc Biol.
13. Speer MY, Yang HY, Brabb T, Leaf E, Look A, et al. (2009) Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res 104: 733-741. doi:10.1161/CIRCRESAHA.108.183053. PubMed: 19197075.
14. Naik V, Leaf EM, Hu JH, Yang HY, Nguyen NB, et al. (2012) Sources of cells that contribute to atherosclerotic intimal calcification: an in vivo genetic fate mapping study. Cardiovasc Res 94: 545-554. doi:10.1093/cvr/cvs126. PubMed: 22436847.
15. Abedin M, Tintut Y, Demer LL, (2004) Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 24: 1161-1170. doi:10.1161/01.ATV.0000133194.94939.42. PubMed: 15155384.
16. Johnson RC, Leopold JA, Loscalzo J, (2006) Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 99: 1044-1059. doi:10.1161/01.RES.0000249379.55535.21. PubMed: 17095733.
17. Shanahan CM, Weissberg PL, Metcalfe JC, (1993) Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res 73: 193-204. doi:10.1161/01.RES.73.1.193. PubMed: 8508530.
18. Boström K, Zebboudj AF, Yao Y, Lin TS, Torres A, (2004) Matrix GLA protein stimulates VEGF expression through increased transforming growth factor-beta1 activity in endothelial cells. J Biol Chem 279: 52904-52913. doi:10.1074/jbc.M406868200. PubMed: 15456771.
19. Crosier MD, Booth SL, Peter I, Dawson-Hughes B, Price PA, et al. (2009) Matrix Gla protein polymorphisms are associated with coronary artery calcification in men. J Nutr Sci Vitaminol (Tokyo) 55: 59-65. doi:10.3177/jnsv.55.59. PubMed: 19352064.
20. Herrmann SM, Whatling C, Brand E, Nicaud V, Gariepy J, et al. (2000) Polymorphisms of the human matrix gla protein (MGP) gene, vascular calcification, and myocardial infarction. Arterioscler Thromb Vasc Biol 20: 2386-2393. doi:10.1161/01.ATV.20.11.2386. PubMed: 11073842.
21. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, et al. (1997) Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386: 78-81. doi:10.1038/386078a0. PubMed: 9052783.
22. Giachelli CM, (2009) The emerging role of phosphate in vascular calcification. Kidney Int 75: 890-897. doi:10.1038/ki.2008.644. PubMed: 19145240.
23. Sage AP, Tintut Y, Demer LL, (2010) Regulatory mechanisms in vascular calcification. Nat Rev Cardiol 7: 528-536. doi:10.1038/nrcardio.2010.115.
24. Beazley KE, Deasey S, Lima F, Nurminskaya MV, (2012) Transglutaminase 2-Mediated Activation of beta-Catenin Signaling Has a Critical Role in Warfarin-Induced Vascular Calcification. Arterioscler Thromb Vasc Biol 32: 123-130. doi:10.1161/ATVBAHA.111.237834. PubMed: 22034513.
25. Beazley KE, Eghtesad S, Nurminskaya MV, (2012) Quercetin attenuates warfarin-induced vascular calcification in vitro independently from Matrix Gla protein. J Biol Chem 288: 2632-2640. PubMed: 23223575.
26. Harwood M, Danielewska-Nikiel B, Borzelleca JF, Flamm GW, Williams GM, et al. (2007) A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol 45: 2179-2205. doi:10.1016/j.fct.2007.05.015. PubMed: 17698276.
27. Huxley RR, Neil HA, (2003) The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies. Eur J Clin Nutr 57: 904-908. doi:10.1038/sj.ejcn.1601624. PubMed: 12879084.
28. Egert S, Bosy-Westphal A, Seiberl J, Kürbitz C, Settler U, et al. (2009) Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr 102: 1065-1074. doi:10.1017/S0007114509359127. PubMed: 19402938.
29. Edwards RL, Lyon T, Litwin SE, Rabovsky A, Symons JD, et al. (2007) Quercetin reduces blood pressure in hypertensive subjects. J Nutr 137: 2405-2411. PubMed: 17951477.
30. Kleemann R, Verschuren L, Morrison M, Zadelaar S, van Erk MJ, et al. (2011) Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis 218: 44-52. doi:10.1016/j.atherosclerosis.2011.04.023. PubMed: 21601209.
31. Bhaskar S, Kumar KS, Krishnan K, Antony H, (2013) Quercetin alleviates hypercholesterolemic diet induced inflammation during progression and regression of atherosclerosis in rabbits. Nutrition 29: 219-229. doi:10.1016/j.nut.2012.01.019. PubMed: 22595451.
32. Valenta T, Hausmann G, Basler K, (2012) The many faces and functions of beta-catenin. EMBO J 31: 2714-2736. doi:10.1038/emboj.2012.150. PubMed: 22617422.
33. Chun JS, Oh H, Yang S, Park M, (2008) Wnt signaling in cartilage development and degeneration. BMB Rep 41: 485-494. doi:10.5483/BMBRep.2008.41.7.485. PubMed: 18682032.
34. Reis M, Liebner S, (2013) Wnt signaling in the vasculature. Exp Cell Res 10: 1317-23. PubMed: 23291327.
35. Goodwin AM, D'Amore PA, (2002) Wnt signaling in the vasculature. Angiogenesis 5: 1-9. doi:10.1023/A:1021563510866. PubMed: 12549854.
36. Beazley KE, Zhang T, Lima F, Pozharskaya T, Niger C, et al. (2012) Implication for transglutaminase 2-mediated activation of beta-catenin signaling in neointimal vascular smooth muscle cells in chronic cardiac allograft rejection. J Heart Lung Transplant 31: 1009-1017. doi:10.1016/j.healun.2012.04.009. PubMed: 22694852.
37. Shao JS, Cai J, Towler DA, (2006) Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol 26: 1423-1430. doi:10.1161/01.ATV.0000220441.42041.20. PubMed: 16601233.
38. Shao JS, Cheng SL, Pingsterhaus JM, Charlton-Kachigian N, Loewy AP, et al. (2005) Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 115: 1210-1220. doi:10.1172/JCI24140. PubMed: 15841209.
39. Caira FC, Stock SR, Gleason TG, McGee EC, Huang J, et al. (2006) Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol 47: 1707-1712. doi:10.1016/j.jacc.2006.02.040. PubMed: 16631011.
40. Ishizeki K, Saito H, Shinagawa T, Fujiwara N, Nawa T, (1999) Histochemical and immunohistochemical analysis of the mechanism of calcification of Meckel's cartilage during mandible development in rodents. J Anat 194: 265-277. doi:10.1046/j.1469-7580.1999.19420265.x. PubMed: 10337959.
41. Ross R, (1971) The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol 50: 172-186. doi:10.1083/jcb.50.1.172. PubMed: 4327464.
42. Kaartinen MT, Murshed M, Karsenty G, McKee MD, (2007) Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice. J Histochem Cytochem 55: 375-386. PubMed: 17189522.
43. Nurminsky D, Shanmugasundaram S, Deasey S, Michaud C, Allen S, et al. (2011) Transglutaminase 2 regulates early chondrogenesis and glycosaminoglycan synthesis. Mech Dev 128: 234-245. doi:10.1016/j.mod.2010.11.007. PubMed: 21129482.
44. Moon RT, Kohn AD, De Ferrari GV, Kaykas A, (2004) WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5: 691-701. doi:10.1038/nrg1427. PubMed: 15372092.
45. Karsenty G, Wagner EF, (2002) Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2: 389-406. doi:10.1016/S1534-5807(02)00157-0. PubMed: 11970890.
46. Tchetina E, Mwale F, Poole AR, (2003) Distinct phases of coordinated early and late gene expression in growth plate chondrocytes in relationship to cell proliferation, matrix assembly, remodeling, and cell differentiation. J Bone Miner Res 18: 844-851. doi:10.1359/jbmr.2003.18.5.844. PubMed: 12733723.
47. Hendrickx M, Leyns L, (2008) Non-conventional Frizzled ligands and Wnt receptors. Dev Growth Differ 50: 229-243. doi:10.1111/j.1440-169X.2008.01016.x. PubMed: 18366384.
48. van Gijn ME, Daemen MJ, Smits JF, Blankesteijn WM, (2002) The wnt-frizzled cascade in cardiovascular disease. Cardiovasc Res 55: 16-24. doi:10.1016/S0008-6363(02)00221-3. PubMed: 12062705.
49. Yano F, Kugimiya F, Ohba S, Ikeda T, Chikuda H, et al. (2005) The canonical Wnt signaling pathway promotes chondrocyte differentiation in a Sox9-dependent manner. Biochem Biophys Res Commun 333: 1300-1308. doi:10.1016/j.bbrc.2005.06.041. PubMed: 15979579.
50. Wang X, Adhikari N, Li Q, Hall JL, (2004) LDL receptor-related protein LRP6 regulates proliferation and survival through the Wnt cascade in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 287: H2376-H2383. doi:10.1152/ajpheart.01173.2003. PubMed: 15271658.
51. Faverman L, Mikhaylova L, Malmquist J, Nurminskaya M, (2008) Extracellular transglutaminase 2 activates beta-catenin signaling in calcifying vascular smooth muscle cells. FEBS Lett 582: 1552-1557. doi:10.1016/j.febslet.2008.03.053. PubMed: 18405667.
52. El-Maadawy S, Kaartinen MT, Schinke T, Murshed M, Karsenty G, et al. (2003) Cartilage formation and calcification in arteries of mice lacking matrix Gla protein. Connect Tissue Res 44 (Suppl 1):: 272-278. doi:10.1080/713713617. PubMed: 12952208.
53. Speer MY, McKee MD, Guldberg RE, Liaw L, Yang HY, et al. (2002) Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 196: 1047-1055. doi:10.1084/jem.20020911. PubMed: 12391016.
54. Boström KI, Jumabay M, Matveyenko A, Nicholas SB, Yao Y, (2011) Activation of vascular bone morphogenetic protein signaling in diabetes mellitus. Circ Res 108: 446-457. doi:10.1161/CIRCRESAHA.110.236596. PubMed: 21193740.
55. Sharma B, Albig AR, (2012) Matrix Gla protein reinforces angiogenic resolution. Microvasc Res 10: 24-33. PubMed: 23110920.
56. Wong SC, Chan AT, Lo ES, Lo YM, (2005) Nuclear beta-catenin expression is rare and its potential association with short survival in colorectal signet-ring cell carcinoma. Appl Immunohistochem Mol Morphol 13: 248-251. doi:10.1097/01.pai.0000142845.91862.c8. PubMed: 16082250.
57. Vadlamudi U, Espinoza HM, Ganga M, Martin DM, Liu X, et al. (2005) PITX2, beta-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter. J Cell Sci 118: 1129-1137. doi:10.1242/jcs.01706. PubMed: 15728254.
58. Amen M, Liu X, Vadlamudi U, Elizondo G, Diamond E, et. al. (2007) PITX2 and beta-catenin interactions regulate Lef-1 isoform expression. Mol Cell Biol 27: 7560-7573. doi:10.1128/MCB.00315-07. PubMed: 17785445.
59. Moreno CS, Evans CO, Zhan X, Okor M, Desiderio DM, et al. (2005) Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses. Cancer Res 65: 10214-10222. doi:10.1158/0008-5472.CAN-05-0884. PubMed: 16288009.
60. González-Fernández R, Peña O, Hernández J, Martín-Vasallo P, Palumbo A, et al. (2010) FSH receptor, KL1/2, P450, and PAPP genes in granulosa-lutein cells from in vitro fertilization patients show a different expression pattern depending on the infertility diagnosis. Fertil Steril 94: 99-104. doi:10.1016/j.fertnstert.2010.07.412. PubMed: 19342032.
61. Ellies DL, Viviano B, McCarthy J, Rey JP, Itasaki N, et al. (2006) Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. J Bone Miner Res 21: 1738-1749. doi:10.1359/jbmr.060810. PubMed: 17002572.
62. Clements WK, Kim AD, Ong KG, Moore JC, Lawson ND, et al. (2011) A somitic Wnt16/Notch pathway specifies haematopoietic stem cells. Nature 474: 220-224. doi:10.1038/nature10107. PubMed: 21654806.
63. Mason DP, Kenagy RD, Hasenstab D, Bowen-Pope DF, Seifert RA, et al. (1999) Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res 85: 1179-1185. doi:10.1161/01.RES.85.12.1179. PubMed: 10590245.
64. Morvan F, Boulukos K, Clément-Lacroix P, Roman RS, Suc-Royer I, et al. (2006) Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res 21: 934-945. doi:10.1359/jbmr.060311. PubMed: 16753024.
65. Agrotis A, Kanellakis P, Kostolias G, Di Vitto G, Wei C, et al. (2004) Proliferation of neointimal smooth muscle cells after arterial injury. Dependence on interactions between fibroblast growth factor receptor-2 and fibroblast growth factor-9. J Biol Chem 279: 42221-42229. doi:10.1074/jbc.M408121200. PubMed: 15292181.
66. Hung IH, Yu K, Lavine KJ, Ornitz DM, (2007) FGF9 regulates early hypertrophic chondrocyte differentiation and skeletal vascularization in the developing stylopod. Dev Biol 307: 300-313. doi:10.1016/j.ydbio.2007.04.048. PubMed: 17544391.
67. Buxton P, Edwards C, Archer CW, Francis-West P, (2001) Growth/differentiation factor-5 (GDF-5) and skeletal development. J Bone Joint Surg Am 83-A (Suppl 1):: S23-S30. PubMed: 11263662.
68. Zeng Q, Li X, Beck G, Balian G, Shen FH, (2007) Growth and differentiation factor-5 (GDF-5) stimulates osteogenic differentiation and increases vascular endothelial growth factor (VEGF) levels in fat-derived stromal cells in vitro. Bone 40: 374-381. doi:10.1016/j.bone.2006.09.022. PubMed: 17070126.
69. Liu Y, Wang T, Yan J, Jiagbogu N, Heideman DA, et al. (2011) HGF/c-Met signalling promotes Notch3 activation and human vascular smooth muscle cell osteogenic differentiation in vitro. Atherosclerosis 219: 440-447. doi:10.1016/j.atherosclerosis.2011.08.033. PubMed: 21920521.
70. Amano O, Koshimizu U, Nakamura T, Iseki S, (1999) Enhancement by hepatocyte growth factor of bone and cartilage formation during embryonic mouse mandibular development in vitro. Arch Oral Biol 44: 935-946. doi:10.1016/S0003-9969(99)00086-2. PubMed: 10580541.
71. Mosig RA, Dowling O, DiFeo A, Ramirez MC, Parker IC, et al. (2007) Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth. Hum Mol Genet 16: 1113-1123. doi:10.1093/hmg/ddm060. PubMed: 17400654.
72. Furlan F, Galbiati C, Jorgensen NR, Jensen JE, Mrak E, et al. (2007) Urokinase plasminogen activator receptor affects bone homeostasis by regulating osteoblast and osteoclast function. J Bone Miner Res 22: 1387-1396. doi:10.1359/jbmr.070516. PubMed: 17539736.
73. Otto WR, Rao J, (2004) Tomorrow's skeleton staff: mesenchymal stem cells and the repair of bone and cartilage. Cell Prolif 37: 97-110. doi:10.1111/j.1365-2184.2004.00303.x. PubMed: 14871240.
74. French DM, Kaul RJ, D'Souza AL, Crowley CW, Bao M, et al. (2004) WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair. Am J Pathol 165: 855-867. doi:10.1016/S0002-9440(10)63348-2. PubMed: 15331410.
75. Miceli-Libby L, Johnson MJ, Harrington A, Hara-Kaonga B, Ng AK, et al. (2008) Widespread delta-like-1 expression in normal adult mouse tissue and injured endothelium is reflected by expression of the Dll1LacZ locus. J Vasc Res 45: 1-9. doi:10.1159/000113929. PubMed: 17898542.
76. Aitkenhead M, Wang SJ, Nakatsu MN, Mestas J, Heard C, et al. (2002) Identification of endothelial cell genes expressed in an in vitro model of angiogenesis: induction of ESM-1, (beta)ig-h3, and NrCAM. Microvasc Res 63: 159-171. doi:10.1006/mvre.2001.2380. PubMed: 11866539.
77. Dufourcq P, Leroux L, Ezan J, Descamps B, Lamazière JM, et al. (2008) Regulation of endothelial cell cytoskeletal reorganization by a secreted frizzled-related protein-1 and frizzled 4- and frizzled 7-dependent pathway: role in neovessel formation. Am J Pathol 172: 37-49. doi:10.2353/ajpath.2008.070130. PubMed: 18156211.
78. Johnstone SR, Kroncke BM, Straub AC, Best AK, Dunn CA, et al. (2012) MAPK phosphorylation of connexin 43 promotes binding of cyclin E and smooth muscle cell proliferation. Circ Res 111: 201-211. doi:10.1161/CIRCRESAHA.112.272302. PubMed: 22652908.
79. Liao Y, Regan CP, Manabe I, Owens GK, Day KH, et al. (2007) Smooth muscle-targeted knockout of connexin 43 enhances neointimal formation in response to vascular injury. Arterioscler Thromb Vasc Biol 27: 1037-1042. doi:10.1161/ATVBAHA.106.137182. PubMed: 17332489.
80. Loiselle AE, Jiang JX, Donahue HJ, (2012) Gap junction and hemichannel functions in osteocytes. Bone 10: 205-12. PubMed: 23069374.
81. Hamidouche Z, Fromigué O, Ringe J, Häupl T, Marie PJ, (2010) Crosstalks between integrin alpha 5 and IGF2/IGFBP2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiation. BMC Cell Biol 11: 44. doi:10.1186/1471-2121-11-44. PubMed: 20573191.: 44-11.